The disorder is estimated to affect fewer than 1,000 people in the United States, according to data from the National ... to ...

It’s been a year since the gene-editing treatment Casgevy was approved for sickle cell disease and a related blood disorder.

The rock star, who was forced to cancel a US tour earlier this year after being diagnosed with fast-growing lymphoma, was ...

Nine of 11 patients in new brain cancer trial saw their tumors shrink by at least half. One really beat the odds.

An immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant in a Stanford ...

A clinical trial at Stanford Medicine has shown that CAR-T cell therapy, a cancer treatment, can effectively treat brain ...

T-cells are real life saviors. If modified properly, they can save lupus patients from the trouble of taking medicines ...

Mike Peters of The Alarm has appealed to people to become potential stem cell donors. Peters, who was forced to cancel a US ...

The US regulatory agency has pushed the PDUFA date by three months to 18 March 2025 to “allow for more time to review ...

This patent builds on KFSHRC’s 40-year legacy in stem cell innovation, marked by over 7,649 transplants and more than 500 ...

Investigators at Dana-Farber Cancer Institute are opening a new clinical trial to evaluate a novel type of immune cellular ...

OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...